Corbus Pharmaceuticals (3371) Q2 2026 Earnings Report
DE:3371 Q2 2026 EPS Results
- Actual EPS
- -EUR 1.62
- Consensus EPS
- -EUR 1.13
- Beat/Miss
- Missed by -EUR 0.49
- One Year Ago EPS
- -EUR 1.29
DE:3371 Q2 2026 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/06/2026
- Time
- Before Open
- Conference Call
- Thursday, August 6, 2026
DE:3371 Upcoming Earnings
Corbus Pharmaceuticals's next earnings date is estimated for November 10, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:3371 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 10, 2026 | 2026 (Q3) | -1.14- | -1.7 | ― | ― |
| Aug 06, 2026 | 2026 (Q2) | -1.13-1.62 | -1.29 | -25.69% (-0.33) | |
| May 12, 2026 | 2026 (Q1) | -1.09-1.10 | -1.24 | 11.51% (+0.14) | |
| Mar 09, 2026 | 2025 (Q4) | -1.36-1.12 | -0.7 | -60.26% (-0.42) | |
| Nov 12, 2025 | 2025 (Q3) | -1.48-1.70 | -1.03 | -65.22% (-0.67) | |
| Aug 05, 2025 | 2025 (Q2) | -1.34-1.29 | -0.81 | -60.00% (-0.48) | |
| May 06, 2025 | 2025 (Q1) | -1.10-1.24 | -0.74 | -67.47% (-0.50) | |
| Mar 11, 2025 | 2024 (Q4) | -1.13-0.70 | -1.62 | 56.91% (+0.92) | |
| Nov 07, 2024 | 2024 (Q3) | -0.85-1.03 | -2.03 | 49.34% (+1.00) | |
| Aug 06, 2024 | 2024 (Q2) | -1.06-0.81 | -1.84 | 56.10% (+1.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
